Drug
Seasonal Influenza Vaccine
Seasonal Influenza Vaccine: highest development phase Phase 3, developed by Novartis. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| Seasonal Influenza Vaccine NCT00735410 | Phase 3 | Seasonal Influenza, Vaccine |
| Seasonal Influenza Vaccine NCT00734734 | Phase 2 | Interpandemic Influenza |
Latest
No recent events.
Follow Seasonal Influenza Vaccine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.